PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

Shorts always try to bully Retail by sitting on the SP on good...

  1. 2,844 Posts.
    lightbulb Created with Sketch. 714
    Shorts always try to bully Retail by sitting on the SP on good news. The seeds of doubt have been sewn and watered re CR. But even if a CR happens, it will not change the long term equation. There will be a dilution but holders will have a chance to buy before and probably after a CR to avoid real dilution.

    The shorts are not at particularly high levels compared with other perfectly good companies on the ASX200. I think that is because there is a significant upside risk to shorting PAR. One solid deal on MPS or optioning exclusivity on phase 3 positive results will be enough to fund them to ramping production.

    That will be a green light for larger investors to weigh in IMO. Then we can enjoy watching a classic short squeeze. The more the merrier.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $64.76K 212.9K

Buyers (Bids)

No. Vol. Price($)
2 14687 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 27637 6
View Market Depth
Last trade - 14.12pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.